Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|March 22, 2017
High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitorWerner J Geldenhuys, Sadie A Bergeron, Jackie E Mullins, et al.
Expert Opinion on Drug Discovery|May 3, 2011
In vivo brain microdialysis: advances in neuropsychopharmacology and drug discoveryAltaf S Darvesh, Richard T Carroll, Werner J Geldenhuys, et al.
Pesticide Biochemistry and Physiology|April 22, 2025
Mode of toxicity of the β-triketone leptospermone to Aedes aegypti mosquitoesSarah E McComic, Rui Chen, Shova Mishra, et al.
Current Cancer Drug Targets|December 2, 2016
Identification of Novel Agents for the Treatment of Brain Metastases of Breast CancerVinay K Venishetty, Werner J Geldenhuys, Tori B Terell-Hall, et al.
Oncogene|January 12, 2018
LPA signaling is regulated through the primary cilium: a novel target in glioblastomaYuriy V Loskutov, Caryn L Griffin, Kristina M Marinak, et al.
ACS Chemical Biology|October 4, 2022
MitoNEET's Reactivity of Lys55 toward Pyridoxal Phosphate Demonstrates its Activity as a Transaminase EnzymeCourtney Kunk, Josh Kruger, George Mendoza, et al.
Bioorganic & Medicinal Chemistry|May 10, 2005
3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, Tiffany H Nguyen, et al.
Journal of Medicinal Chemistry|March 23, 2012
Identification of a class of novel tubulin inhibitorsXin Yi, Bo Zhong, Kerri M Smith, et al.
The Journal of Biological Chemistry|January 31, 2018
Nudt19 is a renal CoA diphosphohydrolase with biochemical and regulatory properties that are distinct from the hepatic Nudt7 isoformStephanie A Shumar, Evan W Kerr, Werner J Geldenhuys, et al.
Pageof 18